Biomaterial Database

[Sequential analysis of therapeutic trials in hemato-oncology]. 1989

J Bénichou, and E Bellissant, and C Chastang

Département de Biostatistique et Informatique Médicale, Hôpital Saint-Louis, Paris, France.

UI	MeSH Term	Description	Entries
D008495	Medical Oncology	A subspecialty of internal medicine concerned with the study of neoplasms.	Oncology, Medical,Clinical Oncology,Oncology, Clinical
D002986	Clinical Trials as Topic	Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.	Clinical Trial as Topic
D003625	Data Collection	Systematic gathering of data for a particular purpose from various sources, including questionnaires, interviews, observation, existing records, and electronic devices. The process is usually preliminary to statistical analysis of the data.	Data Collection Methods,Dual Data Collection,Collection Method, Data,Collection Methods, Data,Collection, Data,Collection, Dual Data,Data Collection Method,Method, Data Collection,Methods, Data Collection
D006405	Hematology	A subspecialty of internal medicine concerned with morphology, physiology, and pathology of the blood and blood-forming tissues.
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016032	Randomized Controlled Trials as Topic	Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.	Clinical Trials, Randomized,Controlled Clinical Trials, Randomized,Trials, Randomized Clinical

Related Publications

J Bénichou, and E Bellissant, and C Chastang

[Therapeutic development in hemato-oncology].

August 1987, Soins; la revue de reference infirmiere,

J Bénichou, and E Bellissant, and C Chastang

[Therapeutic monoclonal antibodies in hemato-oncology].

January 2009, Revue medicale de Liege,

J Bénichou, and E Bellissant, and C Chastang

Sequential analysis in therapeutic trials.

January 1969, Annual review of medicine,

J Bénichou, and E Bellissant, and C Chastang

Therapeutic Thrombocytapheresis for Symptomatic Thrombocytosis in Hemato-Oncology Patients.

February 2018, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,

J Bénichou, and E Bellissant, and C Chastang

Unmet Needs and Therapeutic Strategies in Cardio-Hemato-Oncology.

January 2018, Acta haematologica,

J Bénichou, and E Bellissant, and C Chastang

[Analysis of the human genome in pediatric hemato-oncology].

November 1990, Anales espanoles de pediatria,

J Bénichou, and E Bellissant, and C Chastang

[Difficulties of therapeutic trials in oncology].

January 1987, Annales de medecine interne,

J Bénichou, and E Bellissant, and C Chastang

Stem cells in hemato-oncology.

January 2006, Journal of stem cells & regenerative medicine,